Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine

In conclusion, MenB-Bio experimental vaccines were well tolerated and immunogenic, thus allowing phase II studies.PMID:34793713 | DOI:10.1016/j.bjid.2021.101652

Source: Braz J Infect Dis - November 18, 2021 Category: Infectious Diseases Authors: R Menezes Martins A R S P érissé L A B Camacho M L Leal M L S Maia A Homma E Jessouroun Source Type: research